Catalyst Wire Dossier Catalyst Wire Dossier

KI1107

· Kuhnil Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KI1107, covering 2017-01-20 to 2017-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled [Phase 3]

See pricing